Heart attacks, Quality of Life and Stroke

Questioning Beta-Blocker Interruption After Heart Attack

CardiacWire

SEPTEMBER 8, 2024

Results from the ABYSS trial surprised many at ESC 2024, finding that patients who continue beta-blocker therapy after heart attacks have better long-term outcomes than patients who stop taking the drugs, and they don’t experience the quality of life downsides that some might expect. vs. 2.5%), and stroke (1% vs. 1%).

Heart Attack

Heart Attack Heart attacks Quality of Life Hospital

Beta Blockers May Not Benefit Many Heart Attack Survivors

DAIC

APRIL 8, 2024

The findings call into question the routine use of beta blockers for all patients following a heart attack, which have stood as a mainstay of care for decades. Approximately 50% of heart attack survivors do not experience heart failure. Over a median follow-up period of 3.5

Heart Attack

Heart Attack Heart attacks Heart Failure Myocardial Infarction

New Guidelines on Peripheral Artery Disease Issued by American Heart Association, American College of Cardiology and Leading Medical Societies

DAIC

MAY 16, 2024

A new joint guideline from the American Heart Association (AHA), the American College of Cardiology (ACC) and nine other medical societies reports early diagnosis and treatment of peripheral artery disease is essential to improve outcomes and reduce amputation risk, heart attack, stroke and death for people with Peripheral Artery Disease (PAD).

Peripheral Arterial Disease

Peripheral Arterial Disease Exercise Ischemia Quality of Life

Webinars

Bridging Innovation & Patient Care: The Growing Role of AI

MORE WEBINARS

Leveraging AI-Enabled Remote Cardiac Monitoring to Improve Cardiovascular Care

DAIC

FEBRUARY 24, 2025

The economic toll also extends beyond direct medical expenses patients also may experience lost wages, travel fatigue, reduced productivity and lower quality of life due to disability or repeated hospitalizations.

Hospital

Hospital Cardiovascular Disease Heart Failure Heart Attack

Shockwave Medical Expands U.S. Peripheral IVL Portfolio with Enhanced Catheter

DAIC

SEPTEMBER 16, 2024

1 People suffering from PAD have not only impaired quality of life but also increased risk of heart attack or stroke. PAD affects more than eight million people aged 40 and older in the United States. 2 CLTI is the most advanced and serious form of PAD, impacting nearly 2 million patients in the U.S.

Peripheral Arterial Disease

Peripheral Arterial Disease Quality of Life Heart Attack Heart attacks

The Great Medication Lottery

Dr. Sanjay Gupta

DECEMBER 19, 2022

Her argument was that she had never had a problem with her heart, did not have a family history of heart disease and therefore did not want to take medications that could cause side effects. All health conditions have to either impact your quality of life adversely or predispose you to some kind of future risk I.e

Heart Attack

Heart Attack Heart attacks Quality of Life Cholesterol

The Importance of Cardiovascular Health: An Overview

GEMMS

NOVEMBER 22, 2023

Good cardiovascular health is essential for maintaining a healthy lifestyle and reducing the risk of heart disease, stroke, and other cardiovascular conditions. By prioritizing cardiovascular health, individuals can improve their quality of life and longevity. Why is cardiovascular health important?

Blood Pressure

Blood Pressure Cholesterol Diet Exercise

Why Exercise Is The Key To A Longer Life

Dr. Paddy Barrett

AUGUST 23, 2024

By the end of this article, you should be convinced that high levels of fitness and daily exercise are a MUST for a longer quality of life without major illness. A higher daily step count is also linked to significantly lower cancer, stroke and heart disease rates.

Exercise

Exercise Dementia Cancer Chronic Disease

WELCOME TO THE PRIMARY BANK OF ASPIRIN

Dr. Sanjay Gupta

AUGUST 31, 2022

In the same sense the best medications to take are those that are both safe but also in the long term offer a substantial return in terms of either improving quality of life and/or an improvement in length of life. Let’s look at length of life: Does Aspirin prevent death or vascular events (i.e

Heart Attack

Heart Attack Heart attacks Quality of Life Blood Clot

Image Analysis Software for Cardiovascular Disease Assessment Gets 510(k) FDA Clearance

DAIC

OCTOBER 1, 2024

“I believe that PlaqueIQ will enable physicians to better ‘see’ the disease—specifically plaque quantity and type—so that we can treat patients with greater precision and in personalized manner, improve their quality of life, and ultimately prevent MI and stroke more effectively.”

Cardiovascular Disease

Cardiovascular Disease Plaque Quality of Life Myocardial Infarction

Cardiovascular Risk: What Men Need To Know

MIBHS

NOVEMBER 15, 2023

Cardiovascular Risk In Men With heart disease being the leading cause of death for men in the United States, accounting for 1 in 4 male deaths, it is essential to explore the key aspects of cardiovascular risk that men need to be aware of. Dr. Ciuffo is an expert in high-risk heart surgery cases.

Blood Pressure

Blood Pressure Cholesterol Heart Disease Risk Factors

Heart Failure – Does Testosterone Hold the Key?

Dr. Sanjay Gupta

MARCH 6, 2022

Heart failure is a chronic clinical syndrome characterised by the inability of the heart to pump out enough blood to meet the body’s requirements. Heart failure or cardiac insufficiency has marked negative effects both on quality of life and quantity of life.

Heart Failure

Heart Failure Quality of Life ACE Inhibitor Exercise

Society for Vascular Surgery Launches Campaign to Help People Maintain Vascular Health

DAIC

OCTOBER 23, 2024

Signs and symptoms of vascular disease (such as pain or swelling in the legs, arms, and feet) can go unnoticed or unrecognized and cause serious or life-threatening complications if left untreated including heart attack, stroke, amputation, and even death.

Peripheral Arterial Disease

Peripheral Arterial Disease Quality of Life Risk Factors Education

New Drug Fails to Improve Diabetes-Related Heart Failure

DAIC

APRIL 9, 2024

At study entry, 38% of the patients were taking sodium glucose cotransporter 2 (SGLT2) inhibitors or glucagon-like peptide-1 receptor agonists (GLP-1 RAs), medications for diabetes that have been shown to have beneficial effects on heart disease, including reducing heart failure, heart attacks and strokes.

Heart Failure

Heart Failure Diabetes Cardiomyopathy Exercise